Avalon GloboCare Overview

  • Founded
  • 2014

Founded
  • Status
  • Public

  • Employees
  • 6

Employees
  • Stock Symbol
  • AVCO

Stock Symbol
  • Investments
  • 6

  • Share Price
  • $0.59

  • (As of Tuesday Closing)

Avalon GloboCare General Information

Description

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 4400 Route 9 South
  • Suite 3100
  • Freehold, NJ 07728
  • United States
+1 (732) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avalon GloboCare Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.59 $0.59 $0.40 - $1.15 $58.4M 89.8M 132K -$0.10

Avalon GloboCare Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 45,129 76,500 93,221 144,242
Revenue 1,409 1,391 1,378 1,546
EBITDA (7,741) (8,451) (12,132) (17,481)
Net Income (8,457) (9,090) (12,679) (18,070)
Total Assets 10,275 10,242 10,366 10,491
Total Debt 3,007 3,298 3,733 3,190
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avalon GloboCare Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avalon GloboCare‘s full profile, request access.

Request a free trial

Avalon GloboCare Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and emp
Biotechnology
Freehold, NJ
6 As of 2021
00.000
000000000 00.000

000000

od tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
0000 000000000
Miramar, FL
00 As of 0000
000000000 -

000000

giat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deser
0000 000000000
Cambridge, MA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avalon GloboCare Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kimera Labs Corporation Miramar, FL 00 000000000 -
000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
00000 000000000000 Venture Capital-Backed Woburn, MA 0 00.00 0000000000 0 00.00
0000000 Private Equity-Backed Prague, Czech Republic 0000 00000 000000&0
000000000 Corporation Melbourne, Australia 00 00000 000000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

Avalon GloboCare Patents

Avalon GloboCare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220031836-A1 Emulsomes comprising s-layer fusion proteins and methods of use thereof Pending 03-Aug-2020 000000000
US-20210403509-A1 S-layer vaccine fusion proteins and methods of use Pending 24-Jun-2020 000000000

Avalon GloboCare Executive Team (6)

Name Title Board Seat Contact Info
David Jin Ph.D Chief Executive Officer & Board Member
Luisa Ingargiola Chief Financial Officer
Meng Li Chief Operating Officer, Operations & Board Member
Jianqiang Li Ph.D Chief Technology Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Avalon GloboCare Board Members (5)

Name Representing Role Since
00000 000 00.0 Avalon GloboCare Chief Executive Officer & Board Member 000 0000
0000 00 Avalon GloboCare Chief Operating Officer, Operations & Board Member 000 0000
000000 0000000 00 Self Board Member 000 0000
0000000 000000 Avalon GloboCare Board Member 000 0000
0000000 0000000 000 Self Board Member 000 0000
To view Avalon GloboCare’s complete board members history, request access »

Avalon GloboCare Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avalon GloboCare Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avalon GloboCare‘s full profile, request access.

Request a free trial

Avalon GloboCare Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 14-Jun-2021 0000000000 Drug Discovery 00000 000
00000000 0000 23-Oct-2018 00000 0000 Drug Discovery 00000 000
000000 000000 01-Sep-2018 00000 0000 Biotechnology 00000 000
0000000 00000 25-Oct-2017 0000000000 00000 Drug Discovery 00000 000
Genexosome Technologies 25-Oct-2017 Merger/Acquisition 00.00 Application Software 00000 000
You’re viewing 5 of 6 investments and acquisitions. Get the full list »